Insight Molecular Diagnostics Inc. Finance Lease, Right-of-Use Asset, Accumulated Amortization
Insight Molecular Diagnostics Inc. (IMDX) had Finance Lease, Right-of-Use Asset, Accumulated Amortization of $226.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Notes › Leases › Assets and Liabilities, Lessee › Finance Lease, Right-of-Use Asset, after Accumulated Amortization
us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization · last filed 2021-05-17
- 2021-03-31: Finance Lease, Right-of-Use Asset, Accumulated Amortization $226.00K.
- 2020-12-31: Finance Lease, Right-of-Use Asset, Accumulated Amortization $180.00K.
| Period end | Finance Lease, Right-of-Use Asset, Accumulated Amortization |
|---|---|
| 2021-03-31 | $226.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $180.00K 10-K · filed 2021-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |